Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in March 2016.
Bio-Techne acquired private research tools company Zephyrus Biosciences Inc. Zephyrus will be rolled up into Bio-Techne's protein platforms division. (Mar.)
Zephyrus, a spin-out of Dr. Amy Herr's UC Berkeley lab in 2013, provides tools for protein analysis at the single-cell...